oral semaglutide novo Novo's reduced risk of multiple diseases Novo says it's submitted obesity

The episode highlights the growing influence of social media in shaping political conversations, where even subtle visual differences can trigger widespread debate, speculation, and division, often blurring the line between reality and interpretation in the middle of an intense election season

Journal of Clinical Medicine, 12 (18), 5921

You have Stokes-Adams syndrome, Wolff-Parkinson-White syndrome, or cardiac block without a pacemaker

Microdosing GLP-1s began emerging as a trend after Wegovy, an Ozempic competitor, was approved by the FDA for obesity in 2021

Insurance will likely require documented insufficient response to Wegovy before approving either newer medication